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This case report describes an atypical presentation of an atypical disease entity: Emphysematous 
Cystitis, a rapidly progressive, ascending urinary tract infection, in an emergency department (ED) 
patient whose chief complaint was abdominal pain and who had a urinalysis not consistent with the 
diagnosis of cystitis.  
[WestJEM. 2008;9:171-173.]
INTRODUCTION
Emphysematous Cystitis (EC) is an uncommon, rapidly 
progressive bacterial infection whereby fermentation of 
albumin or glucose by the urinary pathogen results in gas 
formation in the bladder wall and lumen. Although it is an 
uncommon clinical entity, when present it is seen commonly 
in diabetic patients. Early recognition of EC in the emergency 
department (ED) can prevent morbidity and mortality 
resulting from progression of the infection to Emphysematous 
Pyelonephritis and Urosepsis. 
CASE REPORT
A 59-year-old female presented to the ED with a chief 
complaint of abdominal pain. Her abdominal pain began 
three hours before presentation and had awoken her from 
sleep. This abdominal pain was described as “achy,” 5/10, 
intermittent, and located in the left lower quadrant without 
radiation. She denied nausea or vomiting and had no 
diarrhea or blood in her stools. Review of systems revealed 
that the patient had symptoms of dysuria for one day and 
left-sided flank pain along with her abdominal pain. She 
denied fevers or chills. She stated that, despite taking 
her prescribed insulin injections, her blood sugars have 
been persistently elevated above 400 with her personal 
glucometer. Her past medical history was significant for 
insulin-dependent diabetes mellitus (DM), hypertension, 
and prior cerebrovascular accident. She denied ever 
having any surgeries. She used regular insulin, Lantus 
(insulin glargine), and Ibuprofen. Her family history was 
noncontributory, and she denied alcohol, tobacco, or illicit 
drug use. 
Physical exam revealed a temperature of 36.5° C, 
respiratory rate of 18 breaths per minute, heart rate of 
93 beats per minute, blood pressure of 166/81 mm Hg, 
oxygen saturation of 99% on room air, and capillary blood 
glucose of 447 mg/dL. She was awake, alert, and interacting 
appropriately. Her pupils were equally round and reactive to 
light. The cardiac exam was normal and lungs were clear with 
breath sounds bilaterally. The abdomen was soft with minimal 
tenderness to palpation in the left periumbilical and left lower 
quadrant. There was no guarding or rebound. Extremities were 
warm and well-perfused. The neurological exam revealed no 
deficit.
The metabolic panel revealed sodium of 132 mEq/L 
(normal 135-145), BUN of 45 mg/dL (normal 8-22), Creatinine 
of 2.0 mg/dL (normal 0.5-1.3), glucose of 473 mg/dL, and an 
anion gap of 8.0.  A CBC revealed a white blood cell count of 
12.0 K/MM3 (normal 4.5-11.0) and a manual differential with 
10.10 K/MM3 Neutrophils (normal 0.80-7.70). The hepatic 
panel was remarkable for an alkaline phosphatase of 189 U/L 
(normal 35-115). The urine was visibly clear and non-turbid. 
Urinalysis was leukocyte esterase and nitrate negative, but 
revealed large occult blood, glucosuria, protein of 300 mg/DL, 
and 3-6 WBC/HPF (normal 0-3).
While laboratory studies were pending, the patient 
received one liter IV normal saline, four mg of morphine 
sulfate IV for pain, and 10 units of regular insulin. Despite 
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have worsening 6/10 abdominal pain. Given the patient’s 
presentation of undifferentiated abdominal pain without clear 
etiology and her immunocompromised state, a non-contrast 
computed tomography (CT) scan of the abdomen was ordered. 
The CT scan revealed significant air in the bladder wall 
and lumen consistent with EC, severe left hydroureter and 
hydronephrosis without evidence of stones, and significant 
left perinephric stranding without gas in the renal parenchyma 
(Figure 1). 
A gram of Ceftriaxone and 500 mg of Gentamycin 
were started empirically along with a repeat fluid bolus and 
placement of a Foley catheter. While awaiting consultation 
and admission to the Urology service, the patient complained 
of increased abdominal pain and was increasingly tender 
in the left lower quadrant and suprapubic region. Her heart 
rate was persistently tachycardic (in the 130s), and she 
developed a fever to 39.4°C. In light of developing urosepsis 
and the potential for rapid progression to Emphysematous 
pyelonephritis, Interventional Radiology (IR) was consulted 
and placed a left nephrostomy tube to relieve the functional 
obstruction of the urinary tract just eight hours after the patient 
presented to the ED. After nephrostomy tube placement by IR, 
the patient was admitted to the ICU for close monitoring. The 
urine culture grew out Klebsiella pneumoniae and the patient 
was continued on IV antibiotics. Three days after admission, 
the nephrostomy tube was removed as the patient was able to 
void without use of a foley catheter and was able to control 
her pain. She was subsequently discharged and given a 
prescription for Levofloxacin 500 mg every day for fourteen 
days. 
DISCUSSION
EC, or “Cystitis Emphysematosa”, is a potentially fatal 
necrotizing infection that can begin in the bladder and rapidly 
ascend to the renal parenchyma.1,2 The etiology of EC is 
multifactorial and involves: gas-forming bacteria, decreased 
tissue perfusion, and elevated serum glucose in the context 
of an immunocompromised host such as a diabetic patient.1,4 
The mixed fermentation process of substrates such as glucose 
and albumin within the urinary tract by bacteria results in the 
formation of H2 and CO2 gas both within the urinary tract and 
within the luminal mucosa.2 In addition, bacterial endotoxin 
release may contribute to the inflammatory process by 
inducing paralysis of the urinary tract and thus urinary stasis. 
In this case, left ureteral stasis resulted in urine reflux into 
the renal parenchyma with hydroureter and hydronephrosis. 
Ultimately, this patient required placement of nephrostomy 
tubes to relieve the functional urinary obstruction.
Both the prevalence and the incidence of the spectrum 
of Emphysematous urinary tract infections are unknown, but 
patient demographics are significant for a predilection for 
middle-aged, diabetic women as was the patient that presented 
in this report.3 In general, patients with DM have an increased 
risk of complicated urinary tract infection due to more atypical 
isolated urinary pathogens which thrive in the presence of an 
immunocompromised host.5,6 It is likely that the frequency of 
diagnosis is increasing as the prevalence of DM and use of CT 
scanning for undifferentiated abdominal pain is also increasing. 
Figure 1.  Abdominal CT with arrows demonstrating emphysematous 
changes in the bladder wall
Table 1. Demographics and common pathogens3
Variable Value n/N(%)
Mean age (years) 61.9
Men 49/135 (36%)
Women 86/135 (64%)
Diabetic 90/135 (66.7%)
Type 1 DM 25/52 (48%)
Type 2 DM 27/52 (52%)
Women with DM 61/86 (71%)
Men with DM 25/86 (29%)
Overall death rate 9/135 (7%)
Pathogens (n=119) (%)
     Escherichia coli 69 (58%)
     Klebsiella pneumoniae 25 (21%)
     Enterobacter aerogenes 8 (7%)
     Clostridium perfringens 7 (6%)
     Candida albicans 5 (4%)
     Pseudomonas aeruginosa 3 (3%)
Other 13 (11%)
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The spectrum of presentation of EC is broad; however, 
it is commonly associated with fever, chills, nausea, emesis, 
dysuria, and pneumaturia.7,8 Any patient with air in the 
bladder, not necessarily complicated by an inflammatory 
process or infection, will require inquiry regarding past 
surgical history. Both prior urologic procedure, such as 
cystoscopy, and/or enterovesicular fistula secondary to 
Diverticulitis or Crohn’s disease are known to cause air in the 
bladder and bladder wall. 
Although the diagnosis of urinary tract infection is made 
primarily based on patient history and urinalysis results, 
the diagnosis of EC is made via clinical suspicion and plain 
films and/or CT scan, which carries high sensitivity for the 
diagnosis.9 As in this case, the urinalysis was relatively 
negative and had mild pyuria without bacteriuria lessening 
concern for urinary tract infection. However, clinical suspicion 
for a complicated UTI was raised in this diabetic patient 
with undifferentiated abdominal pain and dysuria who later 
developed fever and chills. The CT scan will demonstrate 
presence of air within the bladder lumen and within the 
bladder wall. In addition, CT can confirm presence alternate 
sources of intraluminal gas such as an enterovesicular fistula. 
Management of EC is correlated with disease severity. As 
in this case, empiric broad-spectrum intravenous antibiotics 
to cover gram-negative and anaerobic urinary pathogens 
was necessary to prevent disease. In rapidly progressive 
cases of EC, pathogens release endotoxins that create 
functional obstruction of the urinary tract via ureteral stasis 
and retrograde flow of urine into the renal parenchyma 
causing hydroureter and hydronephrosis. As a result, urinary 
drainage via cystectomy or nephrostomy tube placement 
may be necessary. Alternatively, there has been a case report 
of hyperbaric oxygen therapy as an adjunctive measure to 
the mainstays of antibiotics, urinary drainage, and fluid 
resuscitation in a case of EC.10 
As reported, the mortality rate of EC is 7%, but 
rapidly progressive forms that result in Emphysematous 
Pyelonephritis can lead to nephrectomy and carry mortality 
rates between 19-75%.11,12 
CONCLUSION
The rapid progression of EC from a lower urinary 
tract infection to a complicated upper urinary tract 
infection warrants recognition of this disease entity by the 
emergency physician. Prior to the development of EC, an 
immunocompromised patient with an uncomplicated urinary 
tract infection may be treated with outpatient oral antibiotics. 
However, symptoms of abdominal pain or persistent dysuria 
in immunocompromised patients with a recently-treated, 
uncomplicated UTI or with a new presentation of symptoms 
should be worked up as undifferentiated abdominal pain of 
an unknown origin.  The presentation of EC can be insidious 
and may present as undifferentiated abdominal pain as in 
this report without initial evidence of urinary tract infection 
as seen in the screening urinalysis. In susceptible patient 
populations, such as in diabetic and immunocompromised 
patients, inclusion of EC in the emergency physician’s 
differential diagnosis will reduce morbidity and mortality of 
this disease entity.  
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